Bonus Biogroup (BBIXF) Financial Statements

12 Followers

Bonus Biogroup Financial Overview

Bonus Biogroup's market cap is currently $134.37M. The company's EPS TTM is $-0.018; its P/E ratio is -21.31; Bonus Biogroup is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	₪ 0.00	₪ 0.00	₪ 0.00	₪ 0.00	₪ 0.00
Gross Profit	₪ -2.76M	₪ -2.79M	₪ -2.76M	₪ -3.37M	₪ -4.10M
Operating Income	₪ -22.64M	₪ -27.84M	₪ -28.34M	₪ -37.05M	₪ -64.73M
EBITDA	₪ -19.88M	₪ -26.20M	₪ -28.14M	₪ -35.13M	₪ -88.01M
Net Income	₪ -24.49M	₪ -27.83M	₪ -28.53M	₪ -38.70M	₪ -90.08M
Balance Sheet
Cash & Short-Term Investments	₪ 228.00K	₪ 6.86M	₪ 12.94M	₪ 53.62M	₪ 79.45M
Total Assets	₪ 15.44M	₪ 23.41M	₪ 44.89M	₪ 74.61M	₪ 104.32M
Total Debt	₪ 8.90M	₪ 10.19M	₪ 11.16M	₪ 11.95M	₪ 12.35M
Net Debt	₪ 8.67M	₪ 3.33M	₪ -1.78M	₪ -41.67M	₪ -67.10M
Total Liabilities	₪ 21.11M	₪ 16.45M	₪ 15.58M	₪ 18.22M	₪ 19.89M
Stockholders' Equity	₪ -5.66M	₪ 6.96M	₪ 29.30M	₪ 56.39M	₪ 84.43M
Cash Flow
Free Cash Flow	₪ -14.95M	₪ -21.72M	₪ -27.22M	₪ -35.20M	₪ -45.65M
Operating Cash Flow	₪ -14.93M	₪ -21.37M	₪ -26.40M	₪ -28.82M	₪ -39.84M
Investing Cash Flow	₪ -12.00K	₪ 12.65M	₪ -14.26M	₪ -6.29M	₪ -6.18M
Financing Cash Flow	₪ 8.41M	₪ 2.55M	₪ -1.16M	₪ 2.13M	₪ 113.42M

Currency in ILS

Bonus Biogroup Earnings and Revenue History

Income Statement >

Bonus Biogroup Debt to Assets

Balance Sheet >

Bonus Biogroup Cash Flow

Cash Flow >

Bonus Biogroup Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >